The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapGrowth
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SBHIX | 24.84 | 0.21 | +0.85% |
Saratoga Health & Biotechnology I | |||
GEICX | 8.80 | 0.07 | +0.80% |
Gabelli Equity Income C | |||
MSPRX | 15.20 | 0.03 | +0.20% |
Morgan Stanley Inst Advantage C | |||
GTDYX | 32.38 | -0.14 | -0.43% |
Invesco EQV Emerging Markets All Cap Y | |||
FHKFX | 8.98 | -0.06 | -0.66% |
Fidelity Series Emerging Markets |
A.I.dvisor indicates that over the last year, VMACX has been closely correlated with FSMAX. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if VMACX jumps, then FSMAX could also see price increases.
Ticker / NAME | Correlation To VMACX | 1D Price Change % | ||
---|---|---|---|---|
VMACX | 100% | N/A | ||
FSMAX - VMACX | 89% Closely correlated | +1.07% | ||
RPTIX - VMACX | 32% Poorly correlated | +0.53% | ||
PAMCX - VMACX | 32% Poorly correlated | +0.53% | ||
RPMGX - VMACX | 32% Poorly correlated | +0.53% | ||
RRMGX - VMACX | 32% Poorly correlated | +0.53% | ||
More |